Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study. (Record no. 20773226)

MARC details
000 -LEADER
fixed length control field 02450 a2200709 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516033543.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201106s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1474-5488
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/S1470-2045(11)70081-X
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Moreau, Philippe
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20110628
245 00 - TITLE STATEMENT
Title Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. The Lancet. Oncology
Date of publication, distribution, etc. May 2011
300 ## - PHYSICAL DESCRIPTION
Extent 431-40 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Asia
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Blood Cells
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Boronic Acids
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Bortezomib
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease-Free Survival
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Administration Schedule
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Europe
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Infusions, Intravenous
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Injections, Subcutaneous
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Kaplan-Meier Estimate
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Multiple Myeloma
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasm Staging
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Peripheral Nervous System Diseases
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Protease Inhibitors
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrazines
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Recurrence
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element South America
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pylypenko, Halyna
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Grosicki, Sebastian
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Karamanesht, Ievgenii
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Leleu, Xavier
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Grishunina, Maria
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rekhtman, Grigoriy
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Masliak, Zvenyslava
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Robak, Tadeusz
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Shubina, Anna
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Arnulf, Bertrand
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kropff, Martin
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cavet, James
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Esseltine, Dixie-Lee
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Feng, Huaibao
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Girgis, Suzette
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name van de Velde, Helgi
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Deraedt, William
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Harousseau, Jean-Luc
773 0# - HOST ITEM ENTRY
Title The Lancet. Oncology
Related parts vol. 12
-- no. 5
-- p. 431-40
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/S1470-2045(11)70081-X">https://doi.org/10.1016/S1470-2045(11)70081-X</a>
Public note Available from publisher's website

No items available.